In the past two years, the Mayo Clinic has provided de-identified patient data to 16 digital companies eager to create health AI products and services. More
Twenty minutes after leaving his job at a Brooklyn hospital on Saturday night, 32-year-old Rayne Valentine was lying in the fetal position on the sidewalk. More
A Bellingham, Wash., emergency physician is suing PeaceHealth and TeamHealth, claiming he was wrongfully terminated for publicly criticizing his hospital's COVID-19 response. More
Watchdog groups want President Trump's new coronavirus vaccine czar to disclose all of his ties to drug companies. More
Across Texas, a growing number of poor, unemployed or unsuspecting patients are being sued for uncollected medical debt in a trend that some see as predatory. More
New details emerge in a lawsuit asserting that chains including CVS, Rite Aid and Walgreens sold millions of pills in small towns but rarely flagged suspicious orders to authorities. More
Critics say the government deserves more credit for tens of millions in public money spent to develop the coronavirus treatment. More
During this unprecedented health crisis, what will it take for hospitals to put aside their rivalries and work together? Shannon Brownlee and Vikas Saini discuss in the latest edition of "Lown Hospitals Q&A." More
Twenty large chains received more than $5 billion in federal grants even while sitting on more than $100 billion in cash. More
A dad in Denver tried to do everything right when COVID symptoms surfaced. Still, he ended up with a huge bill from an insurer that had said it waived cost sharing for coronavirus treatment. More
Mistakes are inevitable. But we can try to do better. More
Maine investigators find one patient’s saga with O’NA HealthCare offers a cautionary tale for anyone looking for cut-rate coverage online. More
Two top FDA officials will recuse themselves from Covid-19 vaccine approval decisions since they are joining a Trump push for approval. More
Remdesivir is the poster child for why we need a new model of drug development for pandemics and neglected diseases that isn't market-based. More
Congress authorized $100 billion for health care providers, both to compensate them for the extra costs associated with caring for patients with COVID-19 and for the revenue that’s not coming in from regular care. They have been required to stop providing most nonemergency services, and many patients are afraid to visit health care facilities. More
Bedaquiline, an important treatment for tuberculosis, costs too much for most people. Johnson & Johnson could sell it for $1 a day and still turn a profit. More
Allergan’s “medical aesthetics” products helped persuade AbbVie to buy the company. But what if the devices driving profit are also endangering women’s health? More
Surgeries are canceled. Business models are shifting. Some of the hardest-hit hospitals may close, leaving patients with fewer options for care. More
After years of undermining health policy to aid their Big Pharma patrons, patient advocacy groups are making claims to federal pandemic relief. More
The disconnect between hospital policy and worker expectations often centers around the lack of clear, direct communication with individual workers who have been potentially exposed to the coronavirus. More